leisure time -WSS

leisure time

author：fashion 2025-10-01 21:36:11 - browse：48

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new era of genetic medicine.

The authorization of the therapy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is itself not a surprise. Clinical trials have shown the one-time treatment enabled many sickle cell patients to live free of debilitating pain crises and relieved thalassemia patients of needing regular blood transfusions, raising hopes that they have been effectively cured. But it also stands as a major achievement, coming just over a decade after the first and seminal lab experiments that showed CRISPR’s potential as a gene-editing tool were published.

In granting conditional approval to the therapy, which will have the brand name Casgevy and is also known as exa-cel, the U.K.’s Medicines and Healthcare products Regulatory Agency jumped ahead of its counterparts in the U.S. and Europe, which are also reviewing the medicine, in greenlighting the globe’s first CRISPR treatment. The MHRA’s authorization is for patients who are at least 12 years old.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Listen: PBM conflicts, RSV vaccines, & the future of flu season

focus

WSS

As a primary care physician, here's how I hope to partner with AI

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Addressing health care workers' trauma can help fight burnout

Option Care buys Amedisys in $3.6 billion home care deal

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Community addresses injustice for Long Island mothers

explore

leisure time

Wikipedia

What does generative AI mean for health care? We asked experts

Reports of telehealth's death have been greatly exaggerated

New air purifier tech could be key to improving indoor air quality

Cue Health, Covid

After affirmative action ruling, medical educators look to 'holistic review'

Study finds gene variants tied to breast cancer risk in Black women

Medical leaders decry Supreme Court decision on affirmative action

Liver decline slowed by off

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

hotspot

New case study details death in closely watched Alzhiemer's trial

When is a doctor not a doctor? Try when patients address women doctors

H5N1 virus can be tracked in retail milk, scientists say

For longer

A new study asks: Are we harming blood donors by taking blood?

For longer

hotspot

focus

knowledge

leisure time